How common are approved EB-2 NIW petitions?

EB-2 NIW petition outcomes vary based on the strength of evidence, the specific criteria addressed, and the adjudicating officer. Each case is evaluated individually based on its own merits and documentation.

How does the Immunology industry affect EB-2 NIW petition outcomes?

The Immunology sector has unique considerations for EB-2 NIW petitions. USCIS evaluates whether the petitioner's qualifications and contributions align with the specific requirements of the visa category. Industry context matters for demonstrating the significance and impact of the petitioner's work.

approved EB-2 (NIW)

Research Associate

Immunology · Slovenia · 2025-02-24

Processing Time

64 days

Decision Date

2025-02-24

Location

New York

This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.

Framework Evaluation

3 of 3 criteria met

1 Substantial Merit and National Importance Met

The endeavor addresses critical challenges in cancer treatment and autoimmune disease management, which directly serves the national interest.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 274 citations demonstrate her expertise and position to lead the proposed research.

3 Waiver Benefit to the US Met

The importance and competitiveness of her research, evidenced by major funding, justifies waiving the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in immunology and a record of 6 peer-reviewed journal articles, 4 abstracts, and 1 preprint. Her work earned 274 citations and was supported by documentation of major research funding and four expert recommendation letters. These credentials satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types

Peer Reviewed Publications

Citations

Reference Letters Dependent

Grants

Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved

Ohio 90 days 2025-01-24

The petitioner proposes to continue his research into the role of immune cells in human diseases, specifically focusing on autoimmunity and tumors. His work aims to develop novel immunotherapies for Diffuse Intrinsic Pontine Glioma (DIPG) and identify new therapeutic targets to improve treatments for cancer and autoimmune conditions.

View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved

California 354 days 2025-04-03

The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.

View Case

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved

323 days 2025-06-16

The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.

View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved

New Jersey 180 days 2025-09-03

The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.

View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Slovenia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-24.

Browse all cases

View Original

At a Glance

Outcome approved

Processing 64 days

Criteria Met 3 / 3

Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813

Success Rate 53.7%

Sustained 2,046

Dismissed 1,671

EB-2 (NIW) Overview EB-2 (NIW) in Slovenia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist

Research Associate

Proposed Endeavor

Framework Evaluation

Why This Petition Was Approved

Evidence

Similar Cases

Postdoctoral Researcher

Research Scientist

Business Manager

Others

Frequently Asked Questions

Browse More Cases

At a Glance

EB-2 (NIW) Case Data

Related Pages

Get Case Insights